HEADER TRANSCRIPTION/PEPTIDE 02-AUG-09 2WP2 TITLE STRUCTURE OF BRDT BROMODOMAIN BD1 BOUND TO A DIACETYLATED HISTONE H4 TITLE 2 PEPTIDE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN TESTIS-SPECIFIC PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BROMODOMAIN 1, RESIDUES 17-136; COMPND 5 SYNONYM: BRDT, RING3-LIKE PROTEIN, BROMODOMAIN-CONTAINING FEMALE COMPND 6 STERILE HOMEOTIC-LIKE PROTEIN; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HISTONE H4; COMPND 10 CHAIN: P, Q; COMPND 11 FRAGMENT: RESIDUES 2-21; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: MOUSE; SOURCE 11 ORGANISM_TAXID: 10090 KEYWDS TRANSCRIPTION-PEPTIDE COMPLEX, TRANSCRIPTION REGULATION, BRDT, KEYWDS 2 ACETYLLYSINE, NUCLEUS, COILED COIL, CHROMOSOMAL PROTEIN, NUCLEOSOME EXPDTA X-RAY DIFFRACTION AUTHOR J.MORINIERE,S.ROUSSEAUX,U.STEUERWALD,M.SOLER-LOPEZ,S.CURTET,A.- AUTHOR 2 L.VITTE,J.GOVIN,J.GAUCHER,K.SADOUL,D.J.HART,J.KRIJGSVELD,S.KHOCHBIN, AUTHOR 3 C.W.MUELLER,C.PETOSA REVDAT 5 01-MAY-24 2WP2 1 REMARK REVDAT 4 08-MAY-19 2WP2 1 REMARK LINK REVDAT 3 28-MAR-12 2WP2 1 KEYWDS JRNL REMARK VERSN REVDAT 2 06-OCT-09 2WP2 1 JRNL REVDAT 1 22-SEP-09 2WP2 0 JRNL AUTH J.MORINIERE,S.ROUSSEAUX,U.STEUERWALD,M.SOLER-LOPEZ,S.CURTET, JRNL AUTH 2 A.-L.VITTE,J.GOVIN,J.GAUCHER,K.SADOUL,D.J.HART,J.KRIJGSVELD, JRNL AUTH 3 S.KHOCHBIN,C.W.MUELLER,C.PETOSA JRNL TITL COOPERATIVE BINDING OF TWO ACETYLATION MARKS ON A HISTONE JRNL TITL 2 TAIL BY A SINGLE BROMODOMAIN. JRNL REF NATURE V. 461 664 2009 JRNL REFN ISSN 0028-0836 JRNL PMID 19794495 JRNL DOI 10.1038/NATURE08397 REMARK 2 REMARK 2 RESOLUTION. 2.37 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.37 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 12142 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 587 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.37 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.52 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1682 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 86 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.037 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1988 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 111 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.86100 REMARK 3 B22 (A**2) : -0.79400 REMARK 3 B33 (A**2) : 1.65500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.154 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.840 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 43.97 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP_ALY.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE FOLLOWING RESIDUES WERE NOT REMARK 3 MODELLED BECAUSE OF POOR DENSITY - CHAIN A RESIDUES 21-26, CHAIN REMARK 3 B RESIDUES 18-26, CHAIN P RESIDUES 1-3 AND 13-20, CHAIN Q REMARK 3 RESIDUES 1 AND 13-20. THE FOLLOWING RESIDUES WERE MODELLED AS REMARK 3 ALANINE - CHAIN A RESIDUES 18-21, CHAIN P RESIDUE 12, AND CHAIN REMARK 3 Q RESIDUE 12. FOLLOWING RESIDUES WERE MODELLED AS ALA: A18-21, REMARK 3 P12, Q12. REMARK 4 REMARK 4 2WP2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-AUG-09. REMARK 100 THE DEPOSITION ID IS D_1290040590. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87260 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12142 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.370 REMARK 200 RESOLUTION RANGE LOW (A) : 44.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: BROMODOMAIN BD2 FROM BRDT REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15 MG/ML BRDT-BD1 PROTEIN WAS MIXED REMARK 280 WITH H4-ACK5/K8 PEPTIDE IN A 1:20 MOLAR RATIO. CRYSTALLIZATION REMARK 280 WAS BY THE HANGING DROP VAPOUR DIFFUSION METHOD FROM 2.4 M REMARK 280 AMMONIUM SULFATE, 0.1 M HEPES PH 7., VAPOR DIFFUSION, HANGING REMARK 280 DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.64650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.95500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.61200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.95500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.64650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.61200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, Q REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 17 REMARK 465 LYS A 22 REMARK 465 LYS A 23 REMARK 465 SER A 24 REMARK 465 GLY A 25 REMARK 465 ARG A 26 REMARK 465 GLU B 17 REMARK 465 TYR B 18 REMARK 465 ILE B 19 REMARK 465 ASN B 20 REMARK 465 THR B 21 REMARK 465 LYS B 22 REMARK 465 LYS B 23 REMARK 465 SER B 24 REMARK 465 GLY B 25 REMARK 465 ARG B 26 REMARK 465 SER P 1 REMARK 465 GLY P 2 REMARK 465 ARG P 3 REMARK 465 GLY P 14 REMARK 465 ALA P 15 REMARK 465 LYS P 16 REMARK 465 ARG P 17 REMARK 465 HIS P 18 REMARK 465 ARG P 19 REMARK 465 LYS P 20 REMARK 465 SER Q 1 REMARK 465 GLY Q 14 REMARK 465 ALA Q 15 REMARK 465 LYS Q 16 REMARK 465 ARG Q 17 REMARK 465 HIS Q 18 REMARK 465 ARG Q 19 REMARK 465 LYS Q 20 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 18 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A 19 CG1 CG2 CD1 REMARK 470 ASN A 20 CG OD1 ND2 REMARK 470 THR A 21 CB OG1 CG2 REMARK 470 LYS P 12 CG CD CE NZ REMARK 470 GLY P 13 CA C O REMARK 470 LYS Q 12 CG CD CE NZ REMARK 470 GLY Q 13 CA C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 37 -63.22 -104.16 REMARK 500 THR B 28 162.79 -49.35 REMARK 500 LEU B 62 78.29 -111.29 REMARK 500 LYS P 12 -166.68 36.63 REMARK 500 ARG Q 3 -75.61 -132.90 REMARK 500 ALY Q 8 -9.16 -140.67 REMARK 500 LYS Q 12 -174.40 82.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1U35 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NUCLEOSOME CORE PARTICLECONTAINING THE REMARK 900 HISTONE DOMAIN OF MACROH2A REMARK 900 RELATED ID: 1F66 RELATED DB: PDB REMARK 900 2.6 A CRYSTAL STRUCTURE OF A NUCLEOSOME CORE PARTICLECONTAINING THE REMARK 900 VARIANT HISTONE H2A.Z REMARK 900 RELATED ID: 2WP1 RELATED DB: PDB REMARK 900 STRUCTURE OF BRDT BROMODOMAIN 2 BOUND TO AN ACETYLATED HISTONE H3 REMARK 900 PEPTIDE DBREF 2WP2 A 17 136 UNP Q91Y44 BRDT_MOUSE 17 136 DBREF 2WP2 B 17 136 UNP Q91Y44 BRDT_MOUSE 17 136 DBREF 2WP2 P 1 20 UNP P62806 H4_MOUSE 2 21 DBREF 2WP2 Q 1 20 UNP P62806 H4_MOUSE 2 21 SEQRES 1 A 120 GLU TYR ILE ASN THR LYS LYS SER GLY ARG LEU THR ASN SEQRES 2 A 120 GLN LEU GLN PHE LEU GLN ARG VAL VAL LEU LYS ALA LEU SEQRES 3 A 120 TRP LYS HIS GLY PHE SER TRP PRO PHE GLN GLN PRO VAL SEQRES 4 A 120 ASP ALA VAL LYS LEU LYS LEU PRO ASP TYR TYR THR ILE SEQRES 5 A 120 ILE LYS THR PRO MET ASP LEU ASN THR ILE LYS LYS ARG SEQRES 6 A 120 LEU GLU ASN LYS TYR TYR GLU LYS ALA SER GLU CYS ILE SEQRES 7 A 120 GLU ASP PHE ASN THR MET PHE SER ASN CYS TYR LEU TYR SEQRES 8 A 120 ASN LYS THR GLY ASP ASP ILE VAL VAL MET ALA GLN ALA SEQRES 9 A 120 LEU GLU LYS LEU PHE MET GLN LYS LEU SER GLN MET PRO SEQRES 10 A 120 GLN GLU GLU SEQRES 1 B 120 GLU TYR ILE ASN THR LYS LYS SER GLY ARG LEU THR ASN SEQRES 2 B 120 GLN LEU GLN PHE LEU GLN ARG VAL VAL LEU LYS ALA LEU SEQRES 3 B 120 TRP LYS HIS GLY PHE SER TRP PRO PHE GLN GLN PRO VAL SEQRES 4 B 120 ASP ALA VAL LYS LEU LYS LEU PRO ASP TYR TYR THR ILE SEQRES 5 B 120 ILE LYS THR PRO MET ASP LEU ASN THR ILE LYS LYS ARG SEQRES 6 B 120 LEU GLU ASN LYS TYR TYR GLU LYS ALA SER GLU CYS ILE SEQRES 7 B 120 GLU ASP PHE ASN THR MET PHE SER ASN CYS TYR LEU TYR SEQRES 8 B 120 ASN LYS THR GLY ASP ASP ILE VAL VAL MET ALA GLN ALA SEQRES 9 B 120 LEU GLU LYS LEU PHE MET GLN LYS LEU SER GLN MET PRO SEQRES 10 B 120 GLN GLU GLU SEQRES 1 P 20 SER GLY ARG GLY ALY GLY GLY ALY GLY LEU GLY LYS GLY SEQRES 2 P 20 GLY ALA LYS ARG HIS ARG LYS SEQRES 1 Q 20 SER GLY ARG GLY ALY GLY GLY ALY GLY LEU GLY LYS GLY SEQRES 2 Q 20 GLY ALA LYS ARG HIS ARG LYS MODRES 2WP2 ALY P 5 LYS N(6)-ACETYLLYSINE MODRES 2WP2 ALY P 8 LYS N(6)-ACETYLLYSINE MODRES 2WP2 ALY Q 5 LYS N(6)-ACETYLLYSINE MODRES 2WP2 ALY Q 8 LYS N(6)-ACETYLLYSINE HET ALY P 5 12 HET ALY P 8 12 HET ALY Q 5 12 HET ALY Q 8 12 HETNAM ALY N(6)-ACETYLLYSINE FORMUL 3 ALY 4(C8 H16 N2 O3) FORMUL 5 HOH *111(H2 O) HELIX 1 1 THR A 28 LYS A 44 1 17 HELIX 2 3 SER A 48 GLN A 52 5 5 HELIX 3 4 ASP A 64 ILE A 69 1 6 HELIX 4 5 ASP A 74 ASN A 84 1 11 HELIX 5 6 LYS A 89 ASN A 108 1 20 HELIX 6 7 ASP A 112 SER A 130 1 19 HELIX 7 8 THR B 28 VAL B 37 1 10 HELIX 8 9 VAL B 37 HIS B 45 1 9 HELIX 9 10 SER B 48 GLN B 52 5 5 HELIX 10 11 ASP B 64 ILE B 69 1 6 HELIX 11 12 ASP B 74 ASN B 84 1 11 HELIX 12 13 LYS B 89 ASN B 108 1 20 HELIX 13 14 ASP B 112 SER B 130 1 19 LINK C GLY P 4 N ALY P 5 1555 1555 1.33 LINK C ALY P 5 N GLY P 6 1555 1555 1.33 LINK C GLY P 7 N ALY P 8 1555 1555 1.33 LINK C ALY P 8 N GLY P 9 1555 1555 1.33 LINK C GLY Q 4 N ALY Q 5 1555 1555 1.33 LINK C ALY Q 5 N GLY Q 6 1555 1555 1.33 LINK C GLY Q 7 N ALY Q 8 1555 1555 1.33 LINK C ALY Q 8 N GLY Q 9 1555 1555 1.33 CRYST1 49.293 61.224 97.910 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020287 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016333 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010213 0.00000 MTRIX1 1 0.699950 0.711810 -0.058240 -1.42736 1 MTRIX2 1 0.711220 -0.702150 -0.034010 1.42373 1 MTRIX3 1 -0.065100 -0.017620 -0.997720 -23.26795 1 MTRIX1 2 0.699950 0.711810 -0.058240 -1.42736 1 MTRIX2 2 0.711220 -0.702150 -0.034010 1.42373 1 MTRIX3 2 -0.065100 -0.017620 -0.997720 -23.26795 1